ArticleMethods in molecular biology (Clifton, N.J.)2025
In Vitro and In Vivo Models of Neuroschistosomiasis.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is increasing evidence that various in vitro and in vivo models of neuroschistosomiasis may be useful to study its pathophysiology, the clinical manifestations of the infection, and its effects on cerebral and spinal structures as well as the immune system. The use of animal models to study neuroschistosomiasis began in 1996 with the CD1 mice, followed by studies in Swiss mice, BALB/C mice, C57 mice, New Zealand rabbits, and Wistar rats. These animal models make it possible to study factors that contribute to the spread of the disease, its infectivity, and possible treatment effects. However, better models are needed to fully understand the characteristics of the infection, develop immunotherapies and vaccinations, and figure out how to effectively manage and eradicate it in the long term.
Indexed as
Identifiers
40622535What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.